Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study

在既往接受过免疫检查点抑制剂和化疗的转移性非小细胞肺癌患者中，阿特珠单抗联合贝伐珠单抗（无论是否联合放疗）与多西他赛相比的疗效：来自随机、Ib/II期MORPHEUS-Lung研究的结果